Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA.
Anesthesiology. 2010 Jan;112(1):73-85. doi: 10.1097/ALN.0b013e3181c4a607.
The role of endothelial nitric oxide synthase (eNOS) in isoflurane postconditioning (IsoPC)-elicited cardioprotection is poorly understood. The authors addressed this issue using eNOS mice.
In vivo or Langendorff-perfused mouse hearts underwent 30 min of ischemia followed by 2 h of reperfusion in the presence and absence of postconditioning produced with isoflurane 5 min before and 3 min after reperfusion. Ca+-induced mitochondrial permeability transition (MPT) pore opening was assessed in isolated mitochondria. Echocardiography was used to evaluate ventricular function.
Postconditioning with 0.5, 1.0, and 1.5 minimum alveolar concentrations of isoflurane decreased infarct size from 56 +/- 10% (n = 10) in control to 48 +/- 10%, 41 +/- 8% (n = 8, P < 0.05), and 38 +/- 10% (n = 8, P < 0.05), respectively, and improved cardiac function in wild-type mice. Improvement in cardiac function by IsoPC was blocked by N-nitro-L-arginine methyl ester (a nonselective nitric oxide synthase inhibitor) administered either before ischemia or at the onset of reperfusion. Mitochondria isolated from postconditioned hearts required significantly higher in vitro Ca+ loading than did controls (78 +/- 29 microm vs. 40 +/- 25 microm CaCl2 per milligram of protein, n = 10, P < 0.05) to open the MPT pore. Hearts from eNOS mice displayed no marked differences in infarct size, cardiac function, and sensitivity of MPT pore to Ca+, compared with wild-type hearts. However, IsoPC failed to alter infarct size, cardiac function, or the amount of Ca+ necessary to open the MPT pore in mitochondria isolated from the eNOS hearts compared with control hearts.
IsoPC protects mouse hearts from reperfusion injury by preventing MPT pore opening in an eNOS-dependent manner. Nitric oxide functions as both a trigger and a mediator of cardioprotection produced by IsoPC.
内皮型一氧化氮合酶(eNOS)在异氟醚后处理(IsoPC)诱导的心脏保护中的作用尚未完全阐明。作者使用 eNOS 小鼠解决了这个问题。
在体内或 Langendorff 灌流的小鼠心脏中进行 30 分钟缺血,然后在存在和不存在 IsoPC 的情况下进行 2 小时再灌注,IsoPC 在再灌注前 5 分钟和再灌注后 3 分钟使用。在分离的线粒体中评估 Ca+诱导的线粒体通透性转换(MPT)孔开放。使用超声心动图评估心室功能。
0.5、1.0 和 1.5 个最小肺泡浓度的异氟醚后处理可使对照(n = 10)中的梗死面积从 56 +/- 10%减少至 48 +/- 10%、41 +/- 8%(n = 8,P < 0.05)和 38 +/- 10%(n = 8,P < 0.05),并改善野生型小鼠的心脏功能。IsoPC 改善心脏功能的作用被 N-硝基-L-精氨酸甲酯(一种非选择性一氧化氮合酶抑制剂)阻断,无论是在缺血前还是再灌注开始时给药。与对照组相比,后处理心脏分离的线粒体需要显著更高的体外 Ca+加载才能打开 MPT 孔(78 +/- 29 µm 与 40 +/- 25 µm CaCl2/毫克蛋白质,n = 10,P < 0.05)。与野生型心脏相比,eNOS 小鼠的心脏在梗死面积、心脏功能和 MPT 孔对 Ca+的敏感性方面没有明显差异。然而,与对照心脏相比,IsoPC 未能改变 eNOS 心脏分离的线粒体中的梗死面积、心脏功能或打开 MPT 孔所需的 Ca+量。
IsoPC 通过依赖 eNOS 的方式防止 MPT 孔开放来保护小鼠心脏免受再灌注损伤。一氧化氮既是 IsoPC 产生的心脏保护作用的触发因素,也是其介导物。